Related Experiment Videos
Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations
M Moutafis1, Z Hatahet, M H Castelain
1Service d'Anesthésie, CMC Foch, Suresnes, France.
Intensive Care Medicine
|June 1, 1995
Summary
This study validates the use of an industrial electrochemical device for monitoring nitric oxide (NO) and nitrogen dioxide (NO2) in clinical settings. The Polytron device shows good correlation with the reference chemiluminescence method, making it a viable alternative for routine clinical NO monitoring.
Area of Science:
- Clinical Chemistry
- Medical Instrumentation
- Respiratory Medicine
Background:
- Accurate monitoring of nitric oxide (NO) and nitrogen dioxide (NO2) is crucial for safe clinical application of NO therapy.
- The gold standard chemiluminescence method is impractical for routine clinical use due to cost and logistical constraints.
Purpose of the Study:
- To evaluate the performance of an electrochemical device (Polytrons NO and NO2, Dräger) for measuring NO and NO2 concentrations in a clinical context.
- To compare the accuracy and reliability of the Polytron device against the established chemiluminescence reference method.
Main Methods:
- Simultaneous measurements of NO and oxides of nitrogen (NOx) were conducted using both the Polytron device and chemiluminescence.
- Forty-nine paired measurements were analyzed to assess correlation and agreement between the two methods.
Main Results:
- NO measurements by the Polytron device showed excellent correlation with the chemiluminescence method (r = 0.96, p < 10(-5)).
- A good correlation was also observed for NO2 measurements by Polytron and NOx by chemiluminescence (r = 0.84, p < 10(-5)).
- The Polytron device's ability to detect NO2 in the ppb-range was insufficient to rule out potential toxicity.
Conclusions:
- The Polytron electrochemical device demonstrates good correlation with the reference method for NO monitoring, suggesting its suitability for clinical applications.
- While useful for NO, the Polytron device's limitations in NO2 detection require consideration for comprehensive toxicity assessment.